Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00043836
Status:
COMPLETED
Last Update Posted:
2009-09-02
First Post:
2002-08-14
Brief Title:
The DIAMOND Study Distensibility Improvement And Remodeling in Diastolic Heart Failure
Sponsor:
Synvista Therapeutics Inc
Organization:
Synvista Therapeutics Inc
Study Overview
Official Title:
A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure The DIAMOND Study
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the hypothesis that treatment with oral ALT-711 twice daily for 16 weeks will improve aortic distensibility exercise tolerance and quality of life in elderly patients with isolated diastolic heart failure DHF and that the improvements in exercise tolerance will correlate with the improvements in aortic distensibility
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None